Upcoming Events
The answer to cancer is research.
For over 50 years, ICRF has helped transform cancer research into prominent discoveries across Israel’s leading universities, hospitals, and research institutions.
ICR-funded scientists have driven cutting-edge advancements that have shaped the landscape of cancer diagnosis, treatment, and prognosis worldwide. With the continued support of our donors and partners, ICRF remains committed to advancing life-saving cancer research and bringing us closer to a future without cancer.
Why ICRF
Superb Scientists
Israel has the highest concentration of scientists and physicians per capita
Cost-effective research
Funding scientists in Israel has 30% less overhead costs than North American research
Institution Neutral
Funding goes to scientists at all of Israel’s top biomedical research centers
Targeted Funding
ICRF directly funds individual vetted scientists, rather than “bricks and mortar”
ICRF In the News
ICRF Funded Researcher Yinon Ben-Neriah publishes paper in Nature
nature.com
Yinon Ben-Neriah, ICRF Funded Researcher publishes paper in Nature: The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic Somatic mutations in p53, which inactivate the tumour-suppressor function of p53 and often confer oncogenic gain-of-function properties, are very common in cancer.
Overcoming melanoma’s resistance to anti-cancer drugs
breakingisraelnews.com
Melanoma often presents a rapid resistance to molecular anti-cancer therapies. Although there have been advances in targeted and immunotherapy melanoma treatments in recent years, a substantial percentage of patients fail to respond or develop resistance to such therapies.
Israeli researchers make key discovery that could lead to skin cancer vaccine
israelnationalnews.com
A new study conducted at Tel Aviv University and the Sheba Medical Center reveals how melanoma cancer cells affect their close environment to support their needs – by forming new lymph vessels in the dermis in order to go deeper into the skin and spread through the body. The researchers believe that the new discovery may contribute to the development of a vaccine against the deadly cancer.
Sign up for our newsletter
By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
